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Abstract 
Background: Pseudomonas aeruginosa is an important opportunistic human pathogen that is commonly encoun-
tered clinically in different types of infections. Reporter-gene systems and construction of mutants defective in 
specific functions are useful tools for studying the cellular physiology and virulence of this organism. The common 
mutant construction process requires constructing target alleles into large size suicide vector(s) for transforma-
tions, and extra steps involved in resolving merodiploids. Here we describe a new approach using linearized plasmid 
transformation for creating a green fluorescent protein (GFP) reporter gene system to study promoter activities in P. 
aeruginosa.
Findings: We successfully created promoter–reporter fusion plasmids for studying the promoter activity of virulence 
genes in P. aeruginosa. The promoter of exoenzyme S (a virulence factor) was used in preparation of these fusion 
plasmids. These fusion plasmids were linearized and used directly to transform P. aeruginosa. Stable P. aeruginosa 
chromosomally integrated promoter–reporter fusion mutants were obtained. We demonstrated that the promoter of 
Exoenzyme S gene was activated when P. aeruginosa was grown in a biofilm state, as evidenced by the expression of 
GFP in these biofilm cells.
Conclusion: Direct transformation with linearized plasmid DNA provides another avenue to create P. aeruginosa 
mutants. This new approach eliminates the use of suicide vector(s) for creating P. aeruginosa mutants, and thus speeds 
up the process mutant construction.
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Background
The ubiquitous Gram-negative Pseudomonas aeruginosa 
is an important opportunistic human pathogen. This 
organism has a large genome of 6.3  million nucleotides 
[1], and causes both life-threatening acute infections 
as shown in burn patients, and chronic lung infections 
as in cystic fibrosis patients [2]. P. aeruginosa lives in 
two different life styles, planktonic and biofilm, which 
are thought to be associated with acute infections and 
chronic infections, respectively. The expression of vir-
ulence in P. aeruginosa, which can be influenced by 
environmental signals, is tightly controlled by complex 
regulatory networks. About 8.4 % of predicted P. aerugi-
nosa genes are involved in regulation, which is among 
the highest proportion of predicted regulatory genes 
observed in sequenced bacterial genomes [1]. Therefore, 
it is important to understand the regulatory pathways 
controlling the expression of virulence in P. aeruginosa 
under different conditions and time. This can be accom-
plished by studying the promoter activities of virulence 
genes at both individual and global gene expression levels 
(such as RNA sequencing).
To study the promoter activity of a particular gene, 
the promoter is commonly fused to a reporter gene 
[such as green fluorescent protein (GFP) gene] in a rep-
licative plasmid in order to obtain the highest levels of 
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fluorescence. The resultant plasmid is introduced into the 
host bacterium, and the activities of the reporter gene are 
measured under the desired test conditions. To prevent 
loss of the plasmid, antibiotic is added into the growth 
medium to maintain the selection pressure. However, in 
some circumstances (such as polymicrobial interaction 
studies), the continuous presence of antibiotics to main-
tain the selection pressure is not desirable because some 
interacting strains could be susceptible to the antibiotic. 
In addition, antibiotics themselves can have untoward 
effect on gene expression circuits. Therefore, it is more 
preferable to have the fused promoter–reporter element 
stably integrated into the bacterial chromosome.
Creating stable chromosomal insertion/deletion mutants 
involves several steps [3, 4]. Firstly, target alleles that are 
often tagged with an antibiotic resistance gene are inserted 
into a suicide plasmid. Secondly, the resultant suicide plas-
mid is delivered into the host by electroporation or conjuga-
tion, followed by recombination of the plasmid-borne target 
into the chromosome. Finally, correct mutants are obtained 
by resolving the merodiploids that result from chromo-
somal integration of the suicide plasmid by a single crosso-
ver. This latter procedure uses a counter-selectable marker 
such as Bacillus subtilis sacB (sucrose counter selection). 
Some drawbacks of this conventional approach include: (1) 
difficulties encountered in sacB counter-selection due to 
issues of stringency; and (2) cloning difficulties due to the 
relatively large sizes of suicide plasmids themselves and few 
available cloning sites. In this report, we showed that P. aer-
uginosa mutants can be directly created by electroporation 
of high concentrations of linearized cloning plasmid DNA, 
eliminating the use of a suicide plasmid.
Methods
Growth conditions for bacterial strains and plasmids 
manipulations
Escherichia coli 5α strains used for subcloning and plas-
mid isolation were grown in Luria–Bertani (LB, 10  g/l 
of tryptone, 10  g/l of NaCl and 5  g/l of yeast extract) 
medium at 37 °C in the presence of the appropriate selec-
tive substance (10  μg/ml of Gentamicin), or in low salt 
LB medium (10  g/l of tryptone, 5  g/l of NaCl and 5  g/l 
of yeast extract) containing antibiotic zeocin (50 μg/ml) 
(Invitrogen, Carlsbad, CA). E. coli plasmid DNA isola-
tions were carried out by the QIAprep Spin Miniprep 
Kit (QIAGEN, Valencia, CA). Routine procedures were 
employed for manipulation of DNA. Unless specified, P. 
aeruginosa PAO1 was grown in LB and clinical strains 
were grown in brain heart infusion (BHI).
Promoter–reporter fusion plasmid constructions
Steps for inserting the fused promoter–reporter ele-
ment into the P. aeruginosa chromosome are illustrated 
in Fig. 1. Briefly, an approximate 2.2 kb intergenic region 
between open reading frames (ORFs) of PA3835 and 
PA3836—a region without any transcription based on 
our unpublished RNA Sequencing (RNA-Seq) data—was 
PCR-amplified using primers (listed in Additional file 1: 
Table S1) containing XhoI sites, and cloned into clon-
ing vector pDONR/Zeo from Invitrogen. Using the site-
directed mutagenesis method, two unique sites, BglII and 
SpeI, were created sequentially with BglII site located in 
the middle of the intergenic region, and SpeI site located 
at 10  bp up-stream of the BglII site. Using plasmid 
pJQ200 (ATCC®77482) as a template, the gentamicin-
resistance gene with its own promoter, was PCR ampli-
fied with BamHI site-containing primers, digested with 
BamHI, and inserted at the BglII site in the intergenic 
Fig. 1 Schematic of inserting the fused promoter–reporter element 
into P. aeruginosa. a A roughly 2.2 kb intergenic region between ORFs 
of PA3835 and PA3836 was PCR amplified and cloned into vector 
pDONR/Zeo obtained from Invitrogen-Thermo Fisher Scientific 
(Grand Island, NY). b Two unique sites, BglII (B) and Spe I (S) were 
sequentially created by site-directed mutagenesis with the BglII 
site located in the middle of the intergenic region, and the SpeI 
site located at 10 bp upstream of the BglII site. c The gentamicin 
resistance gene (GmR) was amplified by PCR and inserted at the BglII 
site. d The long half-life version of gfp was inserted at the SpeI site, 
generating plasmid pDONR-NT0. e Promoter of PA3841was inserted 
upstream of gfp in pDONR-NT0, creating construct pDONR-NT3841P. 
The final plasmid was digested with XhoI, dephosphorylated, column 
purified and used to electroporate wild-type P. aeruginosa PAO1 
according to a published method [6]. The promoter–reporter element 
was inserted into the chromosome by a double cross-over recombi-
nation event. Primers used were listed in Additional file 1: Table S1
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region. A long half-life version of gfp containing its own 
ribosome binding site with surrounding rrnB T1 ter-
minator sequences was amplified by PCR from vector 
pPROBE-NT [5], and inserted at the SpeI site upstream 
of the gentamicin-resistance marker. This construct was 
designated as pDONR-NT0. It has three unique restric-
tion enzyme cutting sites (XbaI, KpnI & EcoRI) for clon-
ing of any promoter fragment to be studied into the 
upstream of the reporter gfp.
The sequence of the test promoter was PCR ampli-
fied and inserted into upstream of the reporter gfp at 
the unique site(s) (XbaI, KpnI & EcoRI). The resultant 
plasmid was digested with XhoI and dephosphorylated 
using shrimp alkaline phosphatase (rSAP) to prevent self-
religation. The treated and linearized DNA was column 
purified using Wizard SV PCR clean-up mini-column 
from Promega (Madison, WI), and used directly for 
electroporation.
P. aeruginosa transformation
P. aeruginosa electro-competent cells were prepared 
according to a previously published method [6]. Cells 
from 6  ml of an overnight culture grown in LB or BHI 
broth with an optical density of approximately 1.3 
(λ = 600 nm) were harvested, washed, and re-suspended 
in 100  µl room temperature 300  mM sucrose. The cell 
suspension was mixed with approximately 5  µg Wiz-
ard SV PCR clean-up mini-column-purified linearized 
DNA. Transformation was carried out using an ECM630 
Electro Cell Manipulator from BTX (Holliston, MA) in 
a 2  mm gap width electroporation cuvette with the fol-
lowing settings: 25 µF, 189 Ω, and 2.5 kV. Following the 
immediate addition of Super Optimal Broth (SOC) 
medium (0.6  ml) after electroporation, cells were trans-
ferred to a 17  ×  100  mm style 14  ml polypropylene 
round-bottom tube, and incubated for 2 h at 37 °C with 
shaking at 150  rpm. The entire mixture was plated on 
four PIA (Pseudomonas isolation agar; Becton, Dickinson 
and Co.) plates, each containing 40  µg/ml gentamicin. 
After overnight incubation, colonies were analyzed for 
proper double crossover recombination by colony PCR 
based on the sizes of the PCR products.
Growing P. aeruginosa biofilms in the bioflux system
The mid-log phase P. aeruginosa culture was passed 
through a 5-µm syringe filter (Pall Corporation, Ann 
Arbor, MI) to reduce the number of aggregates. For inoc-
ulation, the culture was adjusted to an optical density of 
0.1 at the wavelength of 600  nm (OD600). The channels 
of a 48-well microplate from the Bioflux system (Flux-
ion Biosciences, South San Francisco, CA) were primed 
with media, followed by inoculation of each channel with 
50  µl P. aeruginosa suspension (OD600nm  =  0.1). After 
2 h of attachment, the channels were perfused with 50 % 
BHI medium at a shear flow of 0.55 dyn/cm2 to initiate 
the growth of biofilms. Biofilm formation and green fluo-
rescence were monitored in real time using the LSM710 
confocal microscope (Carl Zeiss MicroImaging, Thorn-
wood, NY).
Results and discussion
To study the promoter activities, we constructed a pro-
moter–reporter fusion plasmid pDONR-NT0 (see Fig. 1). 
This plasmid contains three unique restriction enzyme 
cutting sites (XbaI, KpnI & EcoRI) for cloning of any pro-
moter fragment to be studied into the upstream of the 
long half-life version gfp reporter. Gentamicin-resistance 
marker was used for selection. The insertion site was cho-
sen to be located at the intergenic region between open 
reading frames of PA3835 and PA3836—a region with-
out any transcription based on our unpublished RNA 
Sequencing (RNA-Seq) data. Basic local alignment search 
tool (BLAST) results showed that although the sequence 
could vary, most, if not all, P. aeruginosa strains have this 
intergenic region. Because this region is non-coding and 
lack of transcription activity; therefore, this insertion site 
is not likely to interfere with other gene functions.
To prove the concept of transformation using line-
arized plasmid DNA, we used the promoter element of 
Exoenzyme S structural gene, a type III secretion effector 
and an important virulence factor for P. aeruginosa [7]. 
We amplified this promoter by PCR and cloned it into 
pDONR-NT0 (see Fig.  1) to create pDONR-NT3841P. 
We transformed 5 µg of each of these linearized plasmids 
into P. aeruginosa PAO1 competent cells. The rational 
for using 5  µg total DNA is that this amount has con-
sistently yielded enough transformants for downstream 
characterization in our preliminary determinations. In 
addition, it has been shown that the number of recom-
binants generated from 5  µg total DNA is close to the 
maximum number of transformants that can be obtained 
in other Gram-negative bacteria [8]. Eight and twelve 
transformants were obtained from the pDONR-NT0 
and pDONR-NT3841P transformation respectively. PCR 
analyses confirmed that about 50 % of the transformants 
were correct double crossover recombinants (Table  1). 
The recombinants were designated as P. aeruginosa NT0 
and NT3841P respectively. There was no difference in 
growth patterns between the double crossover recom-
binants obtained vs. wild-type P. aeruginosa PAO1 (data 
not shown). The incorrect double crossover recom-
binants were spontaneous gentamicin-resistant mutants 
and single crossover recombinants that were likely 
resulted from the incomplete enzyme digestions.
To demonstrate the effectiveness of the promoter–
reporter fusion system created, we compared the 
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expression of green fluorescent protein between recom-
binant strains NT0 (promoterless control) and NT3841P 
which contained the promoter of exoenzyme S gene. Our 
transcriptome profiling (RNAseq) showed that the pro-
moter of exoenzyme S gene was activated when P. aer-
uginosa grew in a biofilm. Indeed, as compared to the 
promoterless control, we observed increased fluores-
cence from the NT3841P recombinant grown as biofilms 
in the Bioflux System (Fig. 2). Although biofilm formation 
and type III secretion have been shown to be reciprocally 
regulated in some publications [9], biofilms and type III 
secretion are not mutually exclusive in Pseudomonas aer-
uginosa. Under some growth condition(s), the type III 
effector proteins (such as ExoS and ExoT) were expressed 
in biofilm cells, but not in the planktonic cells [10]. The 
discrepancy may be caused by different growth condi-
tions used in the studies. The Bioflux system that we 
used to grow biofilm is a continuous-flow system which 
more closely mimics the in vivo conditions. Our results 
are in agreement with that of Mikkelsen et  al., showing 
increased ExoS expression in biofilm cells grown in a 
continuous-flow system [10].
To further confirm the effectiveness of the linearized 
plasmid DNA transformation approach, we transformed 
P. aeruginosa PAO1 with other constructs containing the 
promoter of a hypothetical protein (PA45) gene, the pro-
moter of a phosphogluconate dehydratase (PA3194) gene, 
and the promoter of pyochelin (PA4228) gene using dif-
ferent versions of gfp reporter genes. For each transfor-
mation, although there are variations in transformation 
efficiencies, we were able to obtain correct double cross-
over recombinants of these different constructs (Table 1). 
However, we were not able to monitor the activities of 
these promoters using our constructed system, possibly 
due to the weakness of the promoters and/or the test 
conditions are not optimal.
To determine if we can create deletion mutant using 
this linearized plasmid DNA transformation approach, a 
small none-coding regulatory RNA deletion plasmid was 
constructed (by Dr. Rajasekh Karna and Dr. Christine 
Miller in our laboratories) on the pCR2.1 vector back-
bone. The plasmid was linearized and transformed into 
P. aeruginosa PAO1 competent cells. Two hundred and 
eight gentamicin-resistant transformants were obtained. 
PCR analyses of randomly picked eight transformants 
showed that all were correct double crossover deletion 
mutants. We also used this linearized plasmid to trans-
form a highly virulent clinical strain P. aeruginosa strain 
12-4-4-59 [11]. We obtained eight correct double cross-
over deletion mutants. This result suggests that this lin-
earized plasmid DNA transformation approach is not 
limited to PAO1 strain only.
Recombination efficiency could be influenced by the 
size of both the flanking region and the inserted non-
homologous element, and by the surrounding sequence 
contexts. As the size of the inserted non-homologous 
DNA increases, the efficiency decreases exponentially; 
and once it reaches about 6  kb, the recombination effi-
ciency is not detectable [12]. In contrast, as the flank-
ing region size increases, the recombination efficiency 
increases. However, once the flanking region size reaches 
1 kb, the recombination efficiency is not further improved 
[12]. In our case, the sizes of both flanking regions are 
~1  kb, whereas the inserted non-homologous DNA 
is ~3  kb. Therefore, the low recombination efficiency 
observed is not likely due to the length of the flank-
ing regions, but more likely due to the large size of the 
inserted element. The fact that we obtained more dele-
tion mutants supports this. We were not able to improve 
the transformation efficiency by growing P. aeruginosa 
at 42  °C either for overnight or just for 2  h before per-
forming the transformation. The presence of the vector 
in the total electroporated DNA preparation should not 
contribute to the observed low recombination efficiency 
either. In contrary, it may enhance recombination rates 
by saturating endogenous nucleases. It has been shown 
that the presence of carrier oligonucleotides increased 
the frequencies of recombination in both Gram-negative 
bacteria [8] and yeast [13].
Our results showed that P. aeruginosa mutants could 
be generated by electroporation of high concentra-
tions of linearized cloning plasmid DNA. It has been 
reported that P. aeruginosa mutants could be created 
Table 1 Recombination frequencies of P. aeruginosa PAO1 
transformation using linearized plasmid DNA
a NT long half-life version of GFP. ASV short half-life (110 min) version of GFP. 
0 no promoter element. P promoter element from that particular ORF (e.g. 
3841P—promoter from ORF PA3841)
b Ratio # of correct recombinants per # of transformants
Constructsa # Of transfor-
mants
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by electroporation of high concentrations of linear 
DNA, such as chromosomal DNA [6], PCR fragments 
[14], and single stranded synthetic oligonucleotides 
[15]. Compared to other forms of linear DNA, this lin-
ear plasmid DNA approach has two advantages: Firstly, 
this approach is not limited to any particular vector. 
Thus, it would be more convenient to manipulate a 
target region due to wider selections of vectors. Sec-
ondly, because cloning vectors are usually medium-to-
high copy number plasmids, it is easier to obtain large 
quantities of plasmid DNA needed for the transforma-
tions. Compared to the conventional mutant generating 
approach that requires the use of suicide vector(s), this 
linear plasmid DNA approach eliminates the difficult 
subcloning steps into the suicide vector and the time 
consuming steps of resolving merodiploids resulted 
from single crossover events. One limitation of using 
linear plasmid DNA is the low transformation efficien-
cies. However, the number of correct recombinants 
obtained is still more than needed for downstream 
characterization.
Conclusion
Direct transformation with linearized plasmid DNA pro-
vides another avenue to create P. aeruginosa mutants. 
This new approach eliminates the use of suicide vector(s) 
for creating P. aeruginosa mutants, and thus facilitates 
the study of this opportunistic pathogen.
Fig. 2 The promoter of Exoenzyme S gene (PA3841) was activated when P. aeruginosa cells were in the biofilm state. Recombinants P. aerugi-
nosa NT0 & NT3841P were grown at 37 °C in a 48-well microplate Bioflux system (Fluxion Biosciences, South San Francisco, CA) with a shear flow 
of 0.55 dyn/cm2 using 50 % BHI (Brain Heart Infusion) medium. Images were captured after 25- and 45-h growth using a confocal microscope 
(LSM710; Carl Zeiss MicroImaging, Thornwood, NY) with the excitation wavelength set at 488-nm. Left panels and right panels are representative fluo-
rescence images of NT0 and NT3841P mutants respectively. The expression of GFP was increased in the biofilms formed by the NT3841P recombi-
nant, but not in the biofilms formed by the control NT0 recombinant. Bars represent 10 µm
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